US FDA wants COVID boosters targeting Omicron BA.4, BA.5 subvariants | Reuters
The U.S. Food and Drug Administration on Thursday recommended COVID-19 vaccine manufacturers change the design of their booster shots beginning this fall to include components tailored to combat the currently dominant Omicron BA.4 and BA.5 subvariants of the coronavirus.
Hervorragender Text zum Ende der Impfstoffsicherheit in den USA:
The end of Covid-19 vaccine safety science in America
Enter some description here...